PubMed HealthSearch

Biomedical subjects

G J Zwanikken

Publications and source records attributed to G J Zwanikken.

8 recordsLinked to original sources

Continuation and maintenance therapy with antidepressive agents. Meta-analysis of research.

The purpose of this study was to ascertain the clinical benefits of long-term antidepressant drug treatment in patients with recurrent major depression. Bibliographic reviews of four textbooks and five review articles, literature searches using MEDLINE (1977-1987) and EXCERPTA MEDICA (1974-1987), hand-searching of the bibliographies of identified papers, and a private set were used for data identification. The most informative, definitive research report was selected using explicit criteria for evaluating study design and quality, of each described, randomized, controlled, double-blind trial of long-term antidepressant agent treatment. The trials were started at a specified period after recovery from an affective episode, in patients with major depression. Of the fifty-five originally identified articles, nine were selected that specifically addressed this purpose. The basic data were extracted in the form of 2 x 2 tables comparing the number of patients with an affective relapse to those remaining well and meta-analysed. Six of the selected trials addressed continuation and three addressed maintenance therapy. In two trials of continuation and in one trial of maintenance treatment, antidepressants were significantly more active than a placebo. In none of the trials were antidepressants inferior to a placebo. Continuation therapy with antidepressants (amitriptyline and imipramine) is effective. There are insufficient data to allow any conclusions about the efficacy of maintenance therapy with antidepressants, long-term treatment with antidepressants relative to that with lithium carbonate, or long-term antidepressant treatment in patients with chronic depression.

Antidepressive Agents

Continuation and maintenance therapy with antidepressive agents. An overview of research.

The literature was reviewed in order to ascertain the clinical benefits of long-term antidepressant drug treatment in recurrent major depression. Articles describing randomized, controlled, double-blind trials of long-term antidepressant drug treatment, starting at a specified period after recovery from an affective episode, in patients with major depression, were identified and reviewed. The authors describe, evaluate and comment on the design and quality of over 25 identified studies, 18 studies of continuation therapy and 7 of maintenance treatment. The methodological problems which are encountered in this type of research and the sources of bias which invalidate study results, are dealt with systematically. On the basis of this survey, some treatment guidelines and suggestions for future research are given.

Antidepressive Agents

Safety and efficacy of prolonged treatment with Tremblex (dexetimide), an antiparkinsonian agent. A controlled study.

The trial involved 69 female, long-stay inpatients of the Voorburg mental hospital, of a median age of 50 years. Two groups were formed at the start of the trial. The first group (51 patients) on a maintenance therapy with orphenadrine, were now put on oral dexetimide. Individually adapted dosages ranged from 0.5 to 1.5 mg daily. The control group (18 patients) of antiparkinsonian agents did not take any in the course of the study either. After three and six months (end of trial) biochemical and haematologic parameters were assessed. Clinical evaluation of extrapyramidal symptoms was made in the dexetimide group. All patients of the control group and 47 of the dexetimide group completed the trial. Both groups were shown to be comparable with regard to all parameters. Statistical analysis showed significant improvement in dexetimide-patients with regard to gross motor tremor, facial inexpressiveness, parkinsonian gait (after two weeks) + dyskinesia (after six months).

Adult